{{Redirect/ja|Pharmaceutical/ja||Pharmacy/ja|と|Pharmacology/ja|と|Pharmaceutical industry/ja}}
| name = Pharmaceutical drug
...
58 KB (1,845 words) - 17:09, 5 November 2023
...[[beta-agonists]] and may also have some benefits over [[atosiban]] and [[magnesium sulfate]], although [[atosiban]] results in fewer maternal adverse effects.
Nifedipine (initially BAY a1040, then Adalat) was developed by the German pharmaceutical company [[Bayer]], with most initial studies being performed in the early 1
...
13 KB (1,738 words) - 21:46, 15 November 2023
...[[beta-agonists]] and may also have some benefits over [[atosiban]] and [[magnesium sulfate]], although [[atosiban]] results in fewer maternal adverse effects.
Nifedipine (initially BAY a1040, then Adalat) was developed by the German pharmaceutical company [[Bayer]], with most initial studies being performed in the early 1
...
13 KB (1,794 words) - 21:32, 15 November 2023
* [[Magnesium]] supplements raise HDL-C.
=== Pharmaceutical drugs and niacin ===
...
19 KB (2,657 words) - 10:16, 9 March 2024
* [[Magnesium]] supplements raise HDL-C.
=== Pharmaceutical drugs and niacin === <!--T:37-->
...
20 KB (2,751 words) - 10:15, 9 March 2024
{{Redirect|Pharmaceutical||Pharmacy|and|Pharmacology|and|Pharmaceutical industry}}
| name = Pharmaceutical drug
...
52 KB (6,923 words) - 17:09, 5 November 2023
...magnesium in biology|magnesium]]: [[magnesium (pharmaceutical preparation)|magnesium supplementation]]
[[Category:Pharmaceutical sciences]]
...
31 KB (4,067 words) - 16:45, 3 January 2023
{{Redirect|Pharmaceutical||Pharmacy|and|Pharmacology|and|Pharmaceutical industry}}
| name = Pharmaceutical drug
...
54 KB (7,245 words) - 17:08, 5 November 2023